Show simple item record

dc.contributor.authorMackay, Ranald I
dc.contributor.authorStaffurth, J
dc.contributor.authorPoynter, A
dc.contributor.authorRoutsis, D
dc.date.accessioned2010-11-18T11:42:25Z
dc.date.available2010-11-18T11:42:25Z
dc.date.issued2010-10
dc.identifier.citationUK guidelines for the safe delivery of intensity-modulated radiotherapy. 2010, 22 (8):629-35 Clin Oncolen
dc.identifier.issn1433-2981
dc.identifier.pmid20673709
dc.identifier.doi10.1016/j.clon.2010.06.017
dc.identifier.urihttp://hdl.handle.net/10541/115789
dc.description.abstractThis paper outlines the guidelines for the development of intensity-modulated radiotherapy (IMRT) in the UK. The guidelines are designed to cover the complete implementation of IMRT, with guidelines in the following categories: commissioning, quality, clinical, audit, and training and education. These guidelines have been compiled by the Radiotherapy Development Board of the Royal College of Radiologists and will support the safe application of IMRT in the UK.
dc.language.isoenen
dc.subjectIntensity-Modulated Radiotherapyen
dc.subjectCanceren
dc.subjectGuidelinesen
dc.titleUK guidelines for the safe delivery of intensity-modulated radiotherapy.en
dc.typeArticleen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchester, UK. ranald.mackay@physics.cr.man.ac.uken
dc.identifier.journalClinical Oncologyen
html.description.abstractThis paper outlines the guidelines for the development of intensity-modulated radiotherapy (IMRT) in the UK. The guidelines are designed to cover the complete implementation of IMRT, with guidelines in the following categories: commissioning, quality, clinical, audit, and training and education. These guidelines have been compiled by the Radiotherapy Development Board of the Royal College of Radiologists and will support the safe application of IMRT in the UK.


Files in this item

This item appears in the following Collection(s)

Show simple item record